Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
Journal of Bone and Mineral Metabolism|June 10, 2015
Gender- and age-group-specific associations between physical performance and bone mineral density, falls, and osteoporotic fractures in Koreans: the Chungju Metabolic Disease Cohort studyYejee Lim, Kyunghee Kim, Sun-Hee Ko, et al.
Diabetes, Obesity & Metabolism|May 15, 2020
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksSin Gon Kim, Kyoung Jin Kim, Kun Ho Yoon, et al.
Journal of Tissue Engineering and Regenerative Medicine|September 24, 2017
Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South KoreaYeri Alice Rim, Narae Park, Yoojun Nam, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2014
Common and rare variants in the exons and regulatory regions of osteoporosis-related genes improve osteoporotic fracture risk predictionSeung Hun Lee, Moo Il Kang, Seong Hee Ahn, et al.
Diabetes & Metabolism Journal|November 24, 2011
2011 clinical practice guidelines for type 2 diabetes in KoreaSeung-Hyun Ko, Sung-Rea Kim, Dong-Joon Kim, et al.
Diabetes, Obesity & Metabolism|July 29, 2025
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trialEun-Gyoung Hong, Kyung-Wan Min, SungWan Chun, et al.
The Korean Journal of Internal Medicine|February 24, 2006
Prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adultsHyuk Sang Kwon, Yong Moon Park, Hye Jung Lee, et al.
Endocrine Journal|March 31, 2015
A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetesHae Kyung Yang, Kyung Wan Min, Sung Woo Park, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndromeSung-Dae Moon, Jae-Hyun Park, Eun-Min Kim, et al.
Diabetes & Metabolism Journal|May 4, 2011
Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy studyKun Ho Yoon, Jeong Ah Shin, Hyuk Sang Kwon, et al.
Pageof 29